PHARMING GROUP NV - ADR

PHAR is the ticker symbol for Pharming Group N.V., a biopharmaceutical company. The stock represents ownership in a firm focused on developing and commercializing innovative protein replacement therapies and precision medicines for rare and debilitating diseases. Its American Depositary Receipts (ADRs) trade on the Nasdaq under the symbol PHAR. Investors can find the latest company details and stock data on the quote page.

Recent performance for PHAR can be found in the price chart and performance metrics displayed on this page. These show the stock's price changes over various periods, including daily, weekly, and year-to-date. For the most current information, please refer to the live data above.

Valuation for PHAR can be assessed using metrics such as price-to-earnings (P/E), price-to-sales (P/S), and enterprise value-to-EBITDA (EV/EBITDA). Because Pharming is a biopharmaceutical company, investors may also consider its pipeline potential and revenue growth. The latest valuation ratios for PHAR are available on this page.

PHAR may be traded in pre-market and after-hours sessions, depending on your brokerage and the availability of extended-hours trading for this security. These sessions have lower liquidity and wider spreads. Check with your broker for specific trading hours and any restrictions.

Dividend information for PHAR is not provided here. To determine whether Pharming Group currently pays dividends and the amount, please refer to the dividend section on this page or the company's investor relations website.

Earnings reports, including quarterly and annual results, are typically published on the company's investor relations website and filed with the SEC. The financials section on this page may also provide access to earnings data and historical results. For the latest earnings announcements, check those sources.